Hana Chen-Walden
Plus aucun poste en cours
Historique de carrière de Hana Chen-Walden
Anciens postes connus de Hana Chen-Walden
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOXYTRAN, INC. | Directeur/Membre du Conseil | - | 19/04/2024 |
| Independent Dir/Board Member | - | 19/04/2024 | |
| Covalent Group, Inc. | Conseiller Juridique Général | 01/01/2003 | 01/01/2003 |
| NANOMIX CORPORATION | Directeur Technique/Scientifique/R&D | - | - |
Formation de Hana Chen-Walden
| Tel-Aviv University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Israël | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOXYTRAN, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
| Covalent Group, Inc. | Commercial Services |
- Bourse
- Insiders
- Hana Chen-Walden
- Expérience
